TAYSHA GENE THERAPIES INC's ticker is TSHA and the CUSIP is 877619106. A total of 49 filers reported holding TAYSHA GENE THERAPIES INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,290,599 | +378.8% | 724,873 | 0.0% | 0.68% | +377.5% |
| Q2 2023 | $478,416 | -17.5% | 724,873 | 0.0% | 0.14% | -0.7% |
| Q1 2023 | $579,898 | +35302.8% | 724,873 | 0.0% | 0.14% | -68.2% |
| Q4 2022 | $1,638 | -99.9% | 724,873 | 0.0% | 0.45% | +10.3% |
| Q3 2022 | $1,399,000 | -48.1% | 724,873 | 0.0% | 0.41% | -45.1% |
| Q2 2022 | $2,697,000 | -42.9% | 724,873 | 0.0% | 0.74% | -24.9% |
| Q1 2022 | $4,726,000 | -44.0% | 724,873 | 0.0% | 0.99% | -21.2% |
| Q4 2021 | $8,445,000 | -37.4% | 724,873 | 0.0% | 1.25% | -38.5% |
| Q3 2021 | $13,497,000 | – | 724,873 | – | 2.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 1,391,190 | $29,493,000 | 22.62% |
| Octagon Capital Advisors LP | 320,440 | $6,793,000 | 1.41% |
| Artal Group S.A. | 1,040,882 | $22,067,000 | 0.45% |
| Alphabet Inc. | 640,882 | $13,587,000 | 0.28% |
| Nantahala Capital Management | 432,072 | $9,160,000 | 0.26% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 500,000 | $10,600,000 | 0.22% |
| TimesSquare Capital Management, LLC | 683,400 | $14,488,000 | 0.12% |
| Perceptive Advisors | 640,880 | $13,586,000 | 0.09% |
| Virtus ETF Advisers LLC | 8,697 | $184,000 | 0.08% |
| Granite Point Capital Management, L.P. | 50,000 | $1,060,000 | 0.04% |